3
GLIA
Neurons and Glial Cells
Definition: Neurons are cellular components of the nervous system.
Glial Cells: Types of glial cells include:
Astrocytes
Oligodendrocytes
Schwann Cells
Microglia
Astrocytes
History:
Discovered by Otto Deiters in 1860.
Name ‘astrocyte’ given by Mihaly von Lenhossek in 1895.
Main Functions:
Envelop blood vessels and neurons.
Provide metabolic support.
Facilitate transmitter uptake.
Participate in gliotransmission.
Reference: Figley & Stroma, 2011, European J Neurosci.
Capacity of a Single Astrocyte
A single astrocyte can wrap around up to 140,000 synapses in rodents and approximately 2 million synapses in humans.
Chemical Homeostasis and GLT-1
Importance of GLT-1:
GLT-1 (Glutamate Transporter 1): In rodents, analogous to GLAST (Glutamate Aspartate Transporter 1) in humans.
It eliminates over 80% of neuronal and glial extracellular glutamate, essential for preventing excitotoxicity.
Mechanism:
Found primarily in perisynaptic processes (astroglial processes near pre- and postsynaptic sites).
Approximately 75% of glutamate is recycled every 20 seconds.
Excess glutamate binds to neuronal glutamatergic receptors like:
Postsynaptic: NMDA-R and mGluR5.
Presynaptic: mGluR2/3 autoreceptors.
Metabolic Support by Astrocytes
Role of Astrocytes:
Primary producers of lactate, the main energy source for neurons.
Astrocyte-Neuron Lactate Shuttle:
Synaptic glutamate uptake via GLT-1 stimulates blood glucose transfer to astrocytes through glucose transporter 1 (GLUT1).
Glucose is converted into lactate and released back into the synapse for neuronal uptake via monocarboxylate transporters (MCTs).
Necessary for maintaining long-term potentiation (LTP) and overall neuronal excitability.
Excitatory Synapses
Uptake by Astrocytes:
GLT-1 and GLAST uptake synaptic glutamate, converting it into glutamine (a precursor for glutamate) and releasing it back into the synapse for neuronal glutamate production.
Conversion of Glucose:
Blood-derived glucose is converted into D-serine, which serves as the primary co-transporter for NMDA-R, maintaining glutamate homeostasis.
Inhibitory Synapses
Receptors Expressed by Astrocytes:
Astrocytes express GABA-A and GABA-B receptors.
Mechanisms:
GABA-B receptor stimulation activates astroglial calcium flux, leading to glutamate release.
Synaptic GABA uptake occurs via GABA transporters (GAT) 1 and 3.
GABA is converted into glutamine, released back into the synapse.
Notably, astrocytes have been shown to release GABA into synapses in certain regions like the thalamus, maintaining inhibitory tone.
Microglia
Description:
Microglia are small cells in the central nervous system (CNS), representing the resident immune cells (similar to macrophages) and constituting 10% of the brain cell population.
States of Microglia:
Homeostatic (resting): Characterized by actin-dependent filopodia which survey the local environment.
Reactive: Involves the release of both anti- and pro-inflammatory chemicals.
Functions include:
Inflammation.
Clearing debris.
Responding to environmental changes (toxins, drugs of abuse).
Learning-dependent neuroplastic adaptations.
Evolving Understanding of Microglia
Old View: Characterization based on dichotomies (good vs bad).
New View: Recognizes the coexistence of multiple states (e.g., Epigenetic, Activated M1/M2 states).
M1: Pro-inflammatory
M2: Anti-inflammatory
Multidimensional Integration: New approaches include transcriptomic and metabolomic analyses.
Discovery of Microglia
Early Observations:
1899: Franz Nissl first reported rod-shaped cells in human cases.
1913: Cajal provided the first morphological description of microglial cell bodies.
Pío del Río-Hortega is noted for significant methodological advancements for studying microglia.
Further Developments:
By 1966, it was established that rodent microglial cells can proliferate in response to nerve injury (facial nerve axotomy).
Functions of Reactive Microglia
Synaptic Plasticity: Microglia influence synaptic strength, though debate exists over direct vs. indirect influence.
Synaptic Weakening Mechanisms:
Activation of the complement system.
Dendritic secretion of phosphatidylserine.
Astrocyte release of IL-33.
Synaptic Preservation:
CD200 binding to microglial CD200R.
Neuronal release of CD47 and CD55, which blocks activation of the complement system.
Microglia and Synaptic Strengthening
New Dendritic Spine Head Formation: Associated with direct contact between microglia and dendritic spines, important for various behavioral tasks in rodents.
Plasticity Genes: Several genes related to neuroplasticity are tied to microglial reactivity and linked to LTP.
BDNF Release: Microglia release Brain-Derived Neurotrophic Factor (BDNF), vital for cortical plasticity, enhancing dendritic spine formation and aiding in memory and fear-related tasks.
Reactive Microglial Neuronal Regulation
TLR4-MD2 Complex Activation: Stimulates an intracellular cascade resulting in pro-inflammatory and neurotrophic factor release.
TNF-α Effects: Increases postsynaptic calcium-permeable AMPA-R, decreases GABA-AR.
IL-1β Contribution: Influences LTP by modifying postsynaptic NMDA conductance.
BDNF Role: Mechanism remains unclear; appears to increase GABAergic neuron excitability.
Interaction Between Reactive Microglia and Astrocytes
Astrocytic Response:
TNF-α: Downregulates astrocytic GLT-1 and facilitates astroglial glutamate release.
IL-1β: Also downregulates astrocytic GLT-1.
Communication: Under homeostatic conditions, astrocytes and microglia maintain synaptic stability via mutual interactions.
Myelinating Cells
Oligodendrocytes (OL): Located in the CNS, can myelinate multiple axons.
Schwann Cells: Located in the PNS, each myelinates only one axonal segment.
Importance of Myelin
Axonal Ensheathment: OL and Schwann cells form concentric compact layers of myelin around axons, termed internodes, which can vary in size and length.
Myelination Order: Larger axons are typically myelinated before smaller ones due to increased metabolic and conduction efficiency.
Oligodendrocyte Lineage Cells
Historical Context: Pío del Río Hortega published initial studies on oligodendrocytes in 1921; term 'oligodendrocyte' combines Greek roots meaning "few branches".
Three Cellular States:
Oligodendrocyte Precursors (OPCs)
Immature Pre-myelinating Oligodendrocytes
Mature Myelinating Oligodendrocytes
Diversity: Varied development, morphology, origins, and myelinating functions.
Transition from OPC to OL
Processes Involved:
Direct differentiation from OPCs into OLs.
Proliferation and death of OPCs.
Formation, extension, and retraction of new sheaths, along with existing remodelling.
OPC Functions
Active Role in Neuroplasticity:
OPCs express chondroitin sulfate proteoglycan NG2 channels and are involved in LTP modulation.
Glutamate release can stimulate post-synaptic AMPA/NMDA receptors, promoting LTP.
Kir4.1 channels in OPCs help maintain potassium balance in synapses, further stabilizing LTP.
Myelination by Oligodendrocytes
Mechanism:
Coupled with Nodes of Ranvier, supports saltatory conduction, enhancing action potentials.
Saltatory conduction occurs due to high-density voltage-gated sodium and potassium channels between nodes that recharge action potentials.
Myelination patterns can be adaptive, adjusting sheath thickness and node length as per axonal activity levels, improving metabolic support.
Example: Lactate transfer from myelin to axonal mitochondria prevents metabolic loss.
Oligodendrocytes and Synapses
Interactions with Neurons:
OL release of BDNF promotes presynaptic glutamate release which, in turn, stimulates further BDNF release via mGluR binding and TNF-R2 activation for myelination.
Astrocytic and Microglial Contributions:
TNFα interactions with OL receptors can yield both promoting and inhibiting outcomes for myelination.
Microglia play a role in clearing debris and fostering differentiation of OPCs into OLs while facilitating synaptic strength expression.
Future Topics
Next Week's Discussion: Ethics and research methods in clinical populations.
Key Questions:
Considerations when working with clinical populations.
Formulation of complex neuroscience questions using both clinical and preclinical models.